Details for New Drug Application (NDA): 075352
✉ Email this page to a colleague
The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for 075352
Tradename: | SELEGILINE HYDROCHLORIDE |
Applicant: | Novitium Pharma |
Ingredient: | selegiline hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 075352
Mechanism of Action | Monoamine Oxidase Inhibitors Monoamine Oxidase-B Inhibitors |
Suppliers and Packaging for NDA: 075352
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 075352 | ANDA | Marlex Pharmaceuticals, Inc. | 10135-737 | 10135-737-60 | 60 CAPSULE in 1 BOTTLE (10135-737-60) |
SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 075352 | ANDA | Novitium Pharma LLC | 70954-504 | 70954-504-10 | 60 CAPSULE in 1 BOTTLE (70954-504-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 30, 1998 | TE: | AB | RLD: | No |
Complete Access Available with Subscription